Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy

PURPOSE: Few data are available concerning the clinical outcome of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer (mCRPC) in terms of the duration of androgen deprivation therapy (ADT) before diagnosis of CRPC. We investigated the clinical efficacy of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Korean J Urol
Glavni autori: Kim, Ki Bom, Jo, Jung Ki, Ahn, Soyeon, Lee, Sangchul, Jeong, Seong Jin, Hong, Sung Kyu, Byun, Seok-Soo, Lee, Sang Eun
Format: Artigo
Jezik:Inglês
Izdano: The Korean Urological Association 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4534432/
https://ncbi.nlm.nih.gov/pubmed/26279827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2015.56.8.580
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items